Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
- 1 December 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 346 (8988) , 1467-1471
- https://doi.org/10.1016/s0140-6736(95)92477-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Lower patients' cholesterol nowBMJ, 1995
- Discontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?New England Journal of Medicine, 1995
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Cholesterol lowering and mortality: the importance of considering initial level of risk.BMJ, 1993
- Dietary reduction of serum cholesterol concentration: time to think again.BMJ, 1991
- An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.Circulation, 1990
- Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.BMJ, 1990
- United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim resultsBMJ, 1988
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971